![William McVicar](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
William McVicar
Plus aucun poste en cours
Fortune : 30 437 $ au 31/05/2026
Profil
William K.
McVicar is currently Chairman at Decoy Therapeutics, Inc. and Director at Salarius Pharmaceuticals LLC.
Former roles include President, Chief Executive Officer & Director at Flex Pharma, Inc. from 2017 to 2019; Chairman at Salarius Pharmaceuticals, Inc.; Senior Director-Program Planning & Management at Rhone-Poulenc Rorer, Inc.; Director at Satellos Bioscience, Inc. from 2020 to 2025; Vice President-Development Operations at Sumitomo Pharma America, Inc. from 1999 to 2007; Chief Scientific Officer & Executive VP at Inotek Pharmaceuticals Corp.
from 2013 to 2017; and Manager-International Project at Sandoz Pharmaceuticals Corp.
in 1990.
Education includes undergraduate studies at State University of New York College at Oneonta and a doctorate from the University of Vermont.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 19/02/2025 | 4 167 ( 0,02% ) | 30 419 $ | 31/05/2026 | |
0% | 30/04/2026 | 2 ( 0% ) | 18 $ | 31/05/2026 |
Postes actifs de William McVicar
| Sociétés | Poste | Début |
|---|---|---|
Salarius Pharmaceuticals LLC
 Salarius Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures drugs for cancer | Directeur/Membre du Conseil | - |
Anciens postes connus de William McVicar
| Sociétés | Poste | Fin |
|---|---|---|
| SATELLOS BIOSCIENCE INC. | Directeur/Membre du Conseil | 18/06/2025 |
Flex Pharma, Inc.
 Flex Pharma, Inc. Pharmaceuticals: MajorHealth Technology Provides biopharmaceutical services | Directeur Général | 19/07/2019 |
Inotek Pharmaceuticals Corp.
 Inotek Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Engages in the development, discovery and commercialization of therapies for glaucoma and other diseases of the eye | Directeur Technique/Scientifique/R&D | 01/04/2017 |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Corporate Officer/Principal | 01/09/2007 |
Satellos Bioscience, Inc. /Old/
 Satellos Bioscience, Inc. /Old/ BiotechnologyHealth Technology Engages in research and development of stem cell regeneration | Directeur/Membre du Conseil | - |
Formation de William McVicar
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
55
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Health Technology |
Inotek Pharmaceuticals Corp.
Inotek Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Engages in the development, discovery and commercialization of therapies for glaucoma and other diseases of the eye | Health Technology |
Flex Pharma, Inc.
Flex Pharma, Inc. Pharmaceuticals: MajorHealth Technology Provides biopharmaceutical services | Health Technology |
Rhone-Poulenc Rorer, Inc.
 Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets human pharmaceuticals | Health Technology |
State University of New York College at Oneonta
 State University of New York College at Oneonta Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Vermont
 University of Vermont Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sandoz Pharmaceuticals Corp. | |
Salarius Pharmaceuticals LLC
Salarius Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures drugs for cancer | Health Technology |
Satellos Bioscience, Inc. /Old/
Satellos Bioscience, Inc. /Old/ BiotechnologyHealth Technology Engages in research and development of stem cell regeneration | Health Technology |
Salarius Pharmaceuticals, Inc.
 Salarius Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company focused on developing treatment for cancer | Health Technology |
Satellos Bioscience, Inc.
 Satellos Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company, which is focused on the identification, development and commercialization of drug candidates | Health Technology |
Choisissez Zonebourse 
